Adagio Therapeutics OverviewAdagio Therapeutics Other Income Expense Net
Other Income/Expense Net for ADGI.
Quarterly Other Income/Expense
$1.74M
↑ 174.25% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$4.17M
↓ 50.4% YoY
Trailing 12 months ending Mar 31, 2026